Gemoscan's Chief Naturopath Recognized by Peers With Leadership Award
January 14 2013 - 1:00PM
Gemoscan Canada, Inc. (TSX-V:GES) (MUN:1GE) ("Gemoscan" or the
"Company"), a leading owner and marketer of food sensitivity and
dietary management solutions, wishes to congratulate its Chief
Naturopath and Naturopathic Advisor, Mubina Jiwa, N.D., on being
recently awarded a Leadership Pin by Naturopathic Doctors Ontario
("NDO").
In 2011, to mark their 60th Anniversary, NDO began a new
tradition of awarding Leadership Pins to NDs and Corporate Partners
who in the course of their years as members or over the past year
have provided their leadership to the association. This honour was
bestowed upon Dr. Jiwa in recognition of her providing valuable
leadership and expertise to the NDO organization in 2012.
"The Leader Pin is a significant award given to influential
Naturopathic Doctors who are members of Naturopathic Doctors
Ontario, and who have provided valuable leadership and expertise to
our association," said Elias Markou, Chair of NDO.
Dr. Jiwa has been with Gemoscan since 2007. Previously, she was
Associate Professor, and is now Assistant Professor, at the
Canadian College of Naturopathic Medicine. She is a member of
Naturopathic Doctors Ontario and is registered with the Board of
Directors of Drugless Therapy - Naturopathy. Dr. Jiwa has
collaborated on nutrition-related research projects at the
University of British Colombia and on research projects at the
British Colombia Children's Hospital. Dr. Jiwa's program on immuno
food intolerances has been accredited by the Canadian Council on
Continuing Education in Pharmacy. Dr. Jiwa also manages a private
practice in the Greater Toronto Area.
"On behalf of every member of the Gemoscan family, I would like
to congratulate Dr. Jiwa on this wonderful achievement. Her
expertise and integrity are clearly evident in all aspects of her
professional life. I am personally honored to be associated with
Dr. Jiwa and look forward to her ongoing guidance as we continue to
build upon Gemoscan's leadership position in the emerging food
intolerance industry," said Brian Kalish, Gemoscan's President and
Chief Executive Officer.
About Gemoscan Canada, Inc.
Gemoscan is an industry leader in food intolerance management
and maintains a first-to- market position with Canada wide
distribution through select retail partners. Founded in 2003, using
its proprietary patented technology, Gemoscan develops, owns and
markets comprehensive food sensitivity and dietary management
solutions for consumers, including the HEMOCODE™ Food Intolerance
System and the MenuWise™ Food Intolerance Plan, personalized
naturopathically supervised nutritional programs that promote
well-being. Gemoscan is the first and only provider to
commercialize a food intolerance management solution directly to
consumers in partnership with retailers, and today offers the most
comprehensive services available.
Gemoscan Canada, Inc. trades its shares on the Toronto Venture
Exchange under the symbol GES and is quoted on the Munich,
Frankfurt and Stuttgart Stock Exchanges under the symbol 1GE.
Forward-Looking Information
This news release contains certain "forward-looking
information". All statements, other than statements of historical
fact that address activities, events or developments that Gemoscan
believes, expects or anticipates will or may occur in the future.
These forward-looking statements reflect the current expectations
or beliefs of Gemoscan based on information currently available to
Gemoscan. Forward-looking statements are subject to a number of
significant risks and uncertainties and other factors that may
cause the actual results of Gemoscan to differ materially from
those discussed in the forward-looking statements, and even if such
actual results are realized or substantially realized, there can be
no assurance that they will have the expected consequences to, or
effects on Gemoscan. Any forward-looking statement speaks only as
of the date on which it is made and, except as may be required by
applicable securities laws, Gemoscan disclaims any intent or
obligation to update any forward- looking statement, whether as a
result of new information, future events or results or otherwise.
Although Gemoscan believes that the assumptions inherent in the
forward-looking statements are reasonable, forward-looking
statements are not guarantees of future performance and accordingly
undue reliance should not be put on such statements due to the
inherent uncertainty therein.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
CONTACT: Brian Kalish
Chief Executive Officer
Gemoscan Canada, Inc.
416.650.1200
bkalish@hemocode.com
www.gemoscan.com
Media:
Leonard Zehr
Kilmer Lucas Inc.
T: (416) 833-9317
leonard@kilmerlucas.com